<Record>
<Term>Immunoadjuvant QS-DG</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Vaccine Adjuvant</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Immunoadjuvant/Vaccine Adjuvant/Immunoadjuvant QS-DG</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Immunoadjuvant QS-DG</BroaderTerm>
<BroaderTerm>Vaccine Adjuvant</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Immunoadjuvant</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Immunoadjuvant QS-DG</Synonym>
<Synonym>QS-DG</Synonym>
<Description>A synthetic saponin, chemically identical to the natural saponin QS-21, with immunoadjuvant activity. When co-administered with vaccine antigens, immunoadjuvant QS-DG may increase total antitumoral vaccine-specific antibody responses and cytotoxic T-lymphocyte (CTL) responses.</Description>
<Source>NCI Thesaurus</Source>
</Record>
